Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Pilot Study of Epoetin Alfa in Idiopathic Anemia of Aging (IAA)
Authors not listed
National Institute on Aging (NIA) · 2004
Abstract
The purpose of this trial is to examine whether Epoetin Alfa, a hormone stimulating production of red blood cells, can reverse idiopathic anemia.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
Anonymous. (2004). Pilot Study of Epoetin Alfa in Idiopathic Anemia of Aging (IAA). <em>National Institute on Aging (NIA)</em>. https://clinicaltrials.gov/study/NCT00104169
Vancouver
Anonymous. Pilot Study of Epoetin Alfa in Idiopathic Anemia of Aging (IAA). National Institute on Aging (NIA). 2004.
BibTeX
@misc{anon2004PilotS,
title = {Pilot Study of Epoetin Alfa in Idiopathic Anemia of Aging (IAA)},
author = {Anonymous},
journal = {National Institute on Aging (NIA)},
year = {2004},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2004
Open access · US-GOV
A Randomized, Double-blind, Placebo-controlled, Study to Assess Changes in Physical Function in Elderly Patients With Idiopathic Anemia of Aging (IAA) Receiving Epoetin Alfa (PROCRIT�)
Istituto Auxologico Italiano 2020
Open access · US-GOV
Active Navigation Training: an Innovative Embodied-based Training System for Spatial Navigation in Aging
National Institute on Aging (NIA) 2012
Open access · US-GOV
Calcium Channel Splice Variant Expression in Cardiovascular Disease and Aging
Experimental and Therapeutic Medicine 2021
Open access · OA
Cord blood telomere shortening associates with increased gestational age and birth weight in preterm neonates
University of Valencia 2017
Open access · US-GOV
Effects of Feet and Ankle Mobilization on Balance of Older Adults
Baltimore VA Medical Center 2009
Open access · US-GOV